- Home
- LKFN vs HROW Comparison
LKFN vs HROW Comparison
Compare LKFN & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKFN
- HROW
- Stock Information
- Founded
- LKFN 1872
- HROW 1998
- Country
- LKFN United States
- HROW United States
- Employees
- LKFN N/A
- HROW N/A
- Industry
- LKFN Major Banks
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- LKFN Finance
- HROW Health Care
- Exchange
- LKFN Nasdaq
- HROW Nasdaq
- Market Cap
- LKFN 1.7B
- HROW 1.4B
- IPO Year
- LKFN 1997
- HROW N/A
- Fundamental
- Price
- LKFN $65.02
- HROW $39.42
- Analyst Decision
- LKFN Buy
- HROW Strong Buy
- Analyst Count
- LKFN 2
- HROW 7
- Target Price
- LKFN $68.00
- HROW $64.67
- AVG Volume (30 Days)
- LKFN 142.0K
- HROW 486.6K
- Earning Date
- LKFN 10-24-2025
- HROW 08-11-2025
- Dividend Yield
- LKFN 3.07%
- HROW N/A
- EPS Growth
- LKFN N/A
- HROW N/A
- EPS
- LKFN 3.67
- HROW N/A
- Revenue
- LKFN $239,375,000.00
- HROW $227,661,000.00
- Revenue This Year
- LKFN $16.89
- HROW $45.86
- Revenue Next Year
- LKFN $4.98
- HROW $41.41
- P/E Ratio
- LKFN $17.73
- HROW N/A
- Revenue Growth
- LKFN N/A
- HROW 47.69
- 52 Week Low
- LKFN $50.00
- HROW $20.85
- 52 Week High
- LKFN $78.61
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- LKFN 46.50
- HROW 59.01
- Support Level
- LKFN $66.02
- HROW $35.62
- Resistance Level
- LKFN $68.40
- HROW $40.33
- Average True Range (ATR)
- LKFN 1.81
- HROW 1.61
- MACD
- LKFN -0.32
- HROW -0.03
- Stochastic Oscillator
- LKFN 24.87
- HROW 67.50
About LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.